Dr Emily Prewett

Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients with Difficult to Cure Characteristics

T Papaluca, S Roberts, S Strasser, K Stuart, G Farrell, G Macquillan, G Dore, A Wade, J George, S Hazeldine, J O'Beirne, A Wigg, L Fisher, B McGarity, R Sawhney, M Sinclair, J Thomas, I Valiozis, M Weltman, M Wilson, A Woodward, G Ahlenstiel, M Haque, M Levy, E Prewett, W Sievert, S Sood, E Tse, Z Valaydon, S Bowden, M Douglas, K New, J O'Keefe, M Hellard, J Doyle, M Stoove, A Thompson

(2021), Vol. 73, pp. E3288-E3295, Clinical Infectious Diseases, United States, C1

Influence of food and lifestyle on the risk of developing inflammatory bowel disease

O Niewiadomski, C Studd, J Wilson, J Williams, C Hair, R Knight, E Prewett, P Dabkowski, S Alexander, B Allen, D Dowling, W Connell, P Desmond, S Bell

(2016), Vol. 46, pp. 669-676, Internal Medicine Journal, Chichester, Eng., C1

Health care cost analysis in a population-based inception cohort of inflammatory bowel disease patients in the first year of diagnosis

O Niewiadomski, C Studd, C Hair, J Wilson, J McNeill, R Knight, E Prewett, P Dabkowski, D Dowling, S Alexander, B Allen, M Tacey, W Connell, P Desmond, S Bell

(2015), Vol. 9, pp. 988-996, Journal of Crohn's and Colitis, England, C1-1

Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity

O Niewiadomski, C Studd, C Hair, J Wilson, N Ding, N Heerasing, A Ting, J Mcneill, R Knight, J Santamaria, E Prewett, P Dabkowski, D Dowling, S Alexander, B Allen, B Popp, W Connell, P Desmond, S Bell

(2015), Vol. 30, pp. 1346-1353, Journal of Gastroenterology and Hepatology (Australia), Australia, C1-1